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Much of the pronounced host inﬂammatory response that occurs in tuberculosis (TB) is related to failed
immunity against the invading pathogen. The G-protein coupled receptors CXCR1 and CXCR2 are
implicated in important signal transduction pathways in lung inﬂammatory responses. We investigated
the expression and function of these receptors in a simple whole blood model from 24 patients with
pulmonary TB and in subjects with latent TB infection (LTBI). Healthy controls were recruited from close
contacts to the pulmonary index patients. We found that pulmonary TB patients had signiﬁcantly
increased CXCR1 expression on blood cells compared to LTBI subjects and controls (p < 0.001). In
contrast, LTBI subjects had a signiﬁcant increase in CXCR2 expression compared to pulmonary TB pa-
tients (p < 0.001) and controls (p < 0.01). Leukocyte function, measured as oxidative capacity, was
decreased in pulmonary TB patients compared to LTBI and controls (p < 0.001) and correlated with the
increased CXCR1 expression. Leukocyte recruitment, measured as the expression of microRNA-223 was
increased in pulmonary TB patients compared to LTBI (p < 0.05). We found that variations in receptor
expression are linked to disease progression and affect the immune response against Mycobacterium
tuberculosis (Mtb).
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The reason why some individuals develop disease after expo-
sure toMycobacterium tuberculosis (Mtb) while others do not is not
well understood. Predisposing factors include nutritional de-
ﬁciencies that affect the immune system and comorbid medical
conditions, such as cancer, diabetes and HIV infection, but various
host genetic factors are also known [1e4]. The immune response
has a strong inﬂuence, both for the establishment of infection, butepartment of Microbiology,
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Ltd. This is an open access article ualso for subsequent pathogenesis and disease manifestations. In
many exposed individuals Mtb is cleared by innate immunity
before manifest infection and when that fails, infection is
controlled by protective encapsulation in most cases [5,6]. The
exaggerated immune response leading to tissue destruction, as
observed in active TB, is thus seen as a failure of immunity to
eliminate or control the infection.
Inhaled Mtb is phagocytosed by a number of cells in the alveoli,
such as neutrophils, epithelial cells, alveolar macrophages and
dendritic cells [7e10]. Collectively, these target cells initiate a ﬁrst
chemokine and cytokine cascade that attracts other leukocytes and
lymphocytes to the site of infection. The chemokine CXCL8 (IL-8) is
secreted early in the infectious disease process and acts as a strong
neutrophil chemoattractant, but is also chemotactic for monocytes
and lymphocytes [11,12]. Neutrophils are an essential component of
the innate immune system and are the ﬁrst group of cells that
migrate to sites of infection. These leukocytes contribute to the
control of Mtb in infected patients, but sustained neutrophilnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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clearance and disease severity [13,14]. The microRNA-223 was
recently found to control the neutrophil-driven fatal TB inﬂam-
mation by regulating the murine counterpart to human CXCL8 [14].
In TB patients, CXCL8 is found abundantly in sputum, lymph
nodes and plasma [15e18]. CXCL8 binds to two G-protein coupled
receptors, CXCR1 and CXCR2, which are primarily expressed by
neutrophils, but also by peripheral blood mononuclear cells, alve-
olar macrophages, TH cells, alveolar and bronchial epithelial cells,
and vascular cells [8,19e21]. Signalling through these receptors
stimulates chemotaxis of myeloid cells, but they are also involved in
mucus hypersecretion of epithelial cells and increased vascular
permeability of endothelial cells [20,22]. Mtb adherence to cells is
known to trigger signal transduction events involving the G-pro-
teins in actin polymerization with the subsequent uptake of the
bacteria [23e25]. Barrios-Payan recently showed that during latent
infection, Mtb is present in the majority of endothelial and
epithelial cells, but does not provoke an inﬂammatory response or
granuloma formation [26]. Between the two CXCL8 receptors,
CXCR2 has gained particular interest in the pathology of several
pulmonary diseases, such as ischemia/reperfusion injury, chronic
obstructive pulmonary disease and pulmonary ﬁbrosis [27].
Using a simple whole blood model, we investigated the
expression pattern of CXCR1 and CXCR2 in patients with pulmonary
TB, LTBI subjects and close contacts. Additionally, the function of
these receptors were analysed in the different study groups. We
found signiﬁcant differences in receptor expression in pulmonary
TB patients and LTBI subjects. Furthermore, leukocyte capacity to
destroy bacteria was impaired in pulmonary TB patients. The
distinct chemokine receptor expression in active and latent TB
patients could potentially have an impact on future therapies.2. Materials & methods
2.1. Patient parameter description
We prospectively recruited active TB-cases and TB-exposed
controls from the department of Infectious diseases, Skåne Uni-
versity Hospital, Malm€o, Sweden (Figure 1). During a period of
35 months, from January 1st 2012 through November 2014, pa-
tients who met the inclusion criteria (age >18 years, ongoing
treatment for active, microbiologically conﬁrmed, smear positive
pulmonary TB) were offered participation in connection with or-
dinary clinical assessment visit. Patients were excluded if theyFigure 1. Flow chart illustrating the complete recruitment process to the study.participated in other studies or if theywere HIV or hepatitis B and C
positive. Two groups of controls exposed to Mtb were recruited
from contact tracing around sputum smear positive TB patients at
the same department. These groups were categorized as patients
with either latent tuberculosis infection (LTBI) and TB-exposed, but
not infected patients. For this categorization subjects exposed to TB
through close contact with a patient with conﬁrmed, smear posi-
tive, pulmonary TB were investigated with QuantiFERON®-TB Gold
In-Tube (QFT-G; Cellestis Limited, Carnegie, Victoria, Australia).
Asymptomatic individuals with positive QFT-Gs were categorized
as LTBI and were offered Isoniazid preventive therapy (IPT). Sub-
jects with LTBI were followed according to Swedish guidelines for
contact tracing for contagious TB, i.e. 3e18 months from study in-
clusion to exclude signs of active TB. Subjects whowere negative in
QFT-G were categorized as TB-exposed, but not infected patients.
Individuals with inconclusive QFT-G (n ¼ 4) were not eligible for
participation in the study. Among exposed controls with valid QFT-
G result, 19 with LTBI and 25 without infection were considered to
have had very close contact with a sputum smear positive contact
and were offered inclusion. Study subjects originated from Sweden,
Finland, Somalia, Afghanistan, Uganda, Chile, Bosnia, Iran, Thailand,
Zimbabwe, Romania, Cameroon, Syria and Tanzania.
2.2. Sample collection
For the receptor studies, 2  4 ml blood sample was obtained
from each participant in heparin containing blood collection tubes
and in PAXgene Blood RNA Tubes (BD, Sweden), for the leukocyte
receptor analysis, functionality assays and for the preparation of
microRNA. Three additional aliquots were obtained at the same
time for the QFT-G assay.
For the blocking experiments, blood was donated from healthy
volunteers and treated with monoclonal mouse anti-human CXCR1
and/or monoclonal mouse anti-human CXCR2 antibodies (R&D
Systems) 10 mg/ml for 30 min on ice; mouse IgG isotype control,
R&D Systems, Denmark was used as a negative control. The cells
were washed twice in PBS and neutrophil oxidative capacity was
measured by Phagoburst (see below).
2.3. Flow cytometry analysis
CXCR1 and CXCR2 expressionwas investigated by FACS analysis.
Heparinized blood (100 mL/antibody) was mixed with lysis buffer
(BD, Sweden), incubated for 10 min at room temperature and
washed twice in PBS-buffer. After centrifugation at 200 g the
supernatant was discarded and monoclonal IgG-FITC labelled
mouse anti-human CXCR1 or monoclonal mouse anti-human
CXCR2 antibodies (10 mg/ml; R&D Systems, Denmark) were
added. FITC-labelled monoclonal mouse immunoglobulin G (10 mg/
ml; mouse IgG isotype control, R&D Systems, Denmark) was used
as a negative control. The samples were incubated 35 min on ice,
washed two times in PBS and analysed by ﬂow cytometry (Accuri,
Becton Dickinson, Oxford, UK). A total of 5000 cells were counted in
each sample. Mean ﬂuorescence intensities (MFI) were calculated
from the negative control.
2.4. Oxidative burst assay
The oxidative capacity of leukocytes was measured by Phag-
oburst (Glycotope Biotechnology, Heidelberg, Germany) according
to manufacturer's instructions. The experiments were set up using
all three reagents supplemented by the manufacturer, i.e. the
peptide fMLP, released from both gram and gramþ bacteria, as
low stimulus, the plant derived toxin PMA as high stimulus and
Escherichia coli as speciﬁc stimulus. As we were more interested in
Table 1
Patient demographic data.
Active LTBI Controls
Patient (n) 11 13 21
Age (year)
Median 36 39 38
Range 18e79 19e77 18e60
Gender (male/female) (8/3) (9/4) (8/13)
Clinical
Sputum smear positive (%) 73 0 0
Culture-positive (%) 100 0 0
IGRA- positive NA 13 0
Co-morbidity
Diabetes 2 1 0
Rheumatoid arthritis 0 0 1
Asthma 1 0 0
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oxidative burst analysis using E. coli. Brieﬂy, whole blood from
patients and controls (100 mL) was incubated with opsonised E. coli
for 10 min at 37 C. Dihydrorhodamine-123 solution was added
(20 mL) and the samples were incubated 10 min at 37 C. Subse-
quently, the blood was lysed and ﬁxed by the addition of 2 ml of
lysis solution. After 20 min incubation in 37 C, samples were
washed once and ﬁnally incubated for 10 min with 200 ml of DNA
staining solution. The respiratory burst was measured by ﬂow
cytometry (Accuri, Becton Dickinson, Oxford, UK). The mean ﬂuo-
rescence intensity (MFI) of the background (washing solution) was
calculated and subtracted by an overlay technique from the MFI of
the sample. The stability of the ﬂuorescence signal was checked and
adjusted using FluoroSpheres® (Dako, Copenhagen, Denmark).IBD 0 0 12.5. miRNA isolation and quantiﬁcation
Venous blood from participants was collected directly into
PAXgene blood RNA tubes (PreAnalytiX GmbH, Hombrechtikon,
Switzerland) containing a reagent that lyses blood cells and
immediately stabilize intercellular RNA to preserve the gene
expression proﬁle. PAXgene Blood miRNA Kit (PreAnalytiX
GmbH, Hombrechtikon, Switzerland) was used for miRNA
extraction according to the manufacturer's protocol and sub-
jected to on-column DNase I treatment with RNase-free Dnase
(Qiagen). RNA quantity and quality were determined using a
Thermo Scientiﬁc NanoDrop 2000c. Total RNA (50 ng) was
reverse transcribed to cDNA and qRT-PCR was performed to
quantify mature miRNA-223 expression using the TaqMan
miRNA Assay (Applied Biosystems) according to manufacturer's
instructions. Samples were run in duplicates in three different
experiments. A template controls were carried out in each PCR.
Ct is deﬁned as the fractional cycle number at which the ﬂuo-
rescence exceeds the deﬁned threshold. miRNA-103 was chosen
as a reference for data analysis [28] and all fold changes were
calculated using the DCt method [29].2.6. Statistics
Prism 6f for Mac OS X was used for statistical analysis. The
statistical difference between two groups was investigated by
ManneWhitney U test. Multiple comparisons were done by one-
way Analysis of Variance followed by Bonferroni or Dunnett's
post-tests (***p  0.001, **p < 0.01, *p < 0.05, ns ¼ non signiﬁcant).3. Results
3.1. Study population and patient characteristics
During the study period 14 cases of pulmonary TB were iden-
tiﬁed at the study site. Of these, eleven pulmonary TB patients were
assigned into group 1 (active) (Figure 1 and Table 1). Patients were
included 0e7 months after initiation of treatment. In total 225
persons were identiﬁed as exposed to Mtb and subjected to LTBI
investigation. Out of 225 contacts, 51 (22.7%) were deﬁned as
having LTBI, 4 (1.8%) contacts had inconclusive QFT-G results, and
the remaining 170 (75.6%) contacts were QFT-G negative. Ten
contacts declined and 34were included, of which 13with LTBI were
enrolled into group 2 (LTBI). 21 healthy individuals in the patient's
immediate vicinity were recruited as close contacts with the active
patient and were enrolled into group 3 (controls).
There was no difference in age (p < 0.3223) or gender
(p < 0.3161) between the groups (Table 1).3.2. CXCR expression linked to TB stages
Regulation of receptor expression in response to Mtb has been
described before [30,31]. Mtb has been reported both to down-
regulate and to up-regulate the chemokine receptor CCR5 on leu-
kocytes. To investigate CXCR1 and CXCR2 expression during pul-
monary TB and LTBI we adopted a simple whole blood model for
ﬂow cytometer analysis. TB patients had a signiﬁcant increase in
CXCR1 expression (p < 0.001) compared to LTBI subjects and con-
trols (Figure 2 and Supplemented Figure 1). For CXCR2 expression,
the LTBI subjects had a signiﬁcant increase compared to TB patients
(p < 0.001) and controls (p < 0.01).
3.3. miRNA-223 is expressed in active TB
miRNA-223 was recently identiﬁed as regulator of neutrophil
recruitment to the lung during TB [14]. We investigated blood
miRNA-223 proﬁles in TB patients, LTBI subjects and close contacts
(Figure 3). Using the human TaqMan miRNA-223 assay, we iden-
tiﬁed signiﬁcant upregulation of miRNA-223 in TB patients
compared with LTBI cases (*p < 0.05).
3.4. Impaired oxidative burst in active TB patients
CXCR1 has been previously implicated in bacterial killing [32],
while CXCR2 is known to be involved in the release of ﬁbrotic
markers. We investigated the capacity to induce oxidative killing in
whole blood in pulmonary TB patients, LTBI subjects and close
controls (Figure 4). Oxidative burst was signiﬁcantly impaired in
pulmonary TB patients compared to LTBI and controls (Figure 4A;
p < 0.001). We found a strong correlation between increased CXCR1
expression and decreased oxidative burst in pulmonary TB patients
(Figure 4B).
To investigate the connection between CXCR1 expression and
oxidative killing even further, we blocked CXCR1 or CXCR2 in
healthy volunteers before performing the oxidative burst assay
(Figure 4C). Blocking of CXCR1 decreased the capacity to induce
oxidative burst compared to CXCR2 blocking (p < 0.001).
4. Discussion
As an essential component of the innate immune defence, leu-
kocytesmigrate from theblood into inﬂammatory tissue. Inadequate
innate immune responsecould lead todestructionoforganstructure,
a main characteristic of acute tuberculosis. We found an increased
expression of CXCR1 in active pulmonary TB patients, and an
increased CXCR2 receptor expression in LTBI subjects. Latency is
considered today as a state of persistentmycobacteria-speciﬁc T-cell
Figure 2. CXCR expression linked to TB pathology. The expression of CXCR1 and CXCR2
was investigated by monoclonal antibodies in whole blood from pulmonary TB pa-
tients (active, n ¼ 11), LTBI subjects (n ¼ 13) and close contacts (n ¼ 21). (A) CXCR1 was
signiﬁcantly increased in active TB patients (p < 0.001) compared to LTBI subjects and
controls. (B) LTBI subjects had increased CXCR2 expression compared to active TB
patients (p < 0.001) and controls (p < 0.01). The mean ﬂuorescence intensities (MFI)
were calculated from the negative control. Data are presented as min/max with hor-
izontal bar representing mean (ANOVA/Bonferroni post-test and ManneWhitney U
test); *p < 0.05, **p < 0.01, and ***p < 0.001.
Figure 3. Increased miRNA-223 expression in active TB patients. qRT-PCR assay of
miR-223 in peripheral blood from pulmonary TB patients (active, n ¼ 7), LTBI subjects
(n ¼ 7) and close contacts (n ¼ 7). miRNA-223 is signiﬁcantly up-regulated in whole
blood of active TB patients compared with LTBI participants and uninfected controls
(*p < 0.05). Data are presented as Relative miR-223 expression (DCt); ANOVA with
Bonferroni test.
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active TB, which can manifest on a continuum of severity, there is a
spectrum of latent infection. Pro-inﬂammatory cytokines, such as
IFNg and TNFa, are produced in the lung during latent TB infection
and both of these cytokines can regulate CXCR2 expression [35,36].
Generally, the cellular expression of these receptors is dependent on
ligand-induced receptor internalization,whereCXCR1 is internalized
at higher chemokine concentrations than CXCR2, yet recycles back to
the membrane faster [37,38]. However, pulmonary TB patients
entered our study after an average treatment for four months, when
the chemokine cascades that can affect the recycling of CXCR1/2 are
back to normal [39]. The subjects in our control group have been in
close contact with the index patient for a long time, but avoided
infection. However, the statistically signiﬁcant difference in receptor
expression between the groups cannot tell us about biological sig-
niﬁcance, as measured in terms of a biological outcome. From this
perspective, we are currently investigating whether a genetic factor
could be predisposing the exaggerated CXCR1 expression in pulmo-
nary TB patients. Interaction of host cells with the pathogen or parts
of the pathogen can also induce increased receptor expression [31]. A
previous study reported that both CXCR1 and CXCR2 were down-regulated on neutrophils isolated from pulmonary TB patients
compared to healthy volunteers [40]. Another study identiﬁed an
increased CXCR2 expression on isolatedmononuclear cells from two
TB patients [19]. Our results differ, but could be explained with the
controls used, as we compare our results with data obtained from TB
exposed close contacts. Moreover, in both previous studies the leu-
kocytes were isolated from blood before measuring receptor
expression. Since isolation procedure activates cells [41], we chose to
perform the analysis in whole blood.
G protein-coupled receptors (GPCRs), such as CXCR1 and CXCR2,
are important regulators of pulmonary diseases [42]. CXCR2 is of
particular interest since several studies identiﬁed this receptor in
the pathology of a wide diversity of chronic pulmonary diseases and
modulation of CXCR2 function is considered as a possible thera-
peutic strategy. Consistent with the observation in chronic pulmo-
nary diseases we observed an increased CXCR2 expression in LTBI
subjects compared to the pulmonary TB patients and the uninfected
controls. CXCR2 is proposed to be involved in mucus hypersecretion
and neutrophil recruitment in chronic obstructive pulmonary dis-
ease (COPD) [22,43]. Increased receptor expression is found in
injured areas in the lungs of COPD patients, which goes along with
the presence of tissue neutrophils during severe exacerbations of
COPD [43,44]. Interestingly, COPD patients have an increased risk of
developing active TB compared to general population [45] and LTBI
increases the risk of COPD [46]. The role of CXCR1 and CXCR2 in
these progressions is not known, but could be of great interest.
Effective bactericidal activity and cooperation with macro-
phages could theoretically eliminate Mtb at an early stage, but
failure of killing could result in continuous neutrophil trafﬁcking to
the site of infection. MicroRNAs are important regulators of im-
mune responses and could be used as future therapeutic targets.
The expression of microRNA-223 is mostly found in neutrophils
where it controls their activation [47]. We found increased
microRNA-223 expression in the blood of active TB patients
compared to the latent TB patients or index controls. Dorhoi et al.
identiﬁed miRNA-223 in blood and lung parenchyma of tubercu-
losis patients and during experimental mouse models of the dis-
ease [14]. Deletion of microRNA-223 led to decreased neutrophil
inﬁltration and subsequent exacerbated lung inﬂammation. Sus-
tained neutrophil recruitment at the site of disease is thus likely to
contribute to on-going inﬂammation, especially in the context of
Figure 4. Impaired phagocytosis in pulmonary TB patients. Intracellular killing was
investigated with opsonized Escherichia coli by oxidative burst in whole blood from
pulmonary TB patients (active, n ¼ 11), LTBI subjects (n ¼ 13) and close contacts
(n ¼ 21). (A) Pulmonary TB patients showed decreased killing of bacteria showed as a
reduced production of oxidative radicals (p < 0.001) compared to LTBI subjects and
controls. (B) Correlation of CXCR1 expression in pulmonary TB patients (active, n ¼ 11)
with bacterial-killing capacity. Bacterial killing capacity is shown as percentage of
negative control and the MFI for CXCR1 expression was calculated from the negative
control. (C) Blocking of CXCR1 or CXCR2 by monoclonal antibodies in healthy volun-
teers (n ¼ 8) before performing the assay for bacterial killing. Blocking of CXCR1
decreased the phagocytic capacity compared to CXCR2 blocking. Un-blocked cells were
used as control (p < 0.001). Data were analyzed by regression curve after one-way
ANOVA/Bonferroni post-test and ManneWhitney U test.
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essential role for a single miRNA in tuberculosis and the potential of
miRNAs for diagnosis and therapy of tuberculosis is currently
considered [48,49].
Despite evidence that CXCR1 and CXCR2 signal through similar G
proteins, there are marked differences in the activation of signalling
cascades, which may identify disparate physiological roles under
inﬂammatory conditions. CXCR1 is the functionally important re-
ceptor involved in neutrophil degranulation [50e53], while CXCR2
activation is coupled to the releaseof elastase,markersofﬁbrosis, and
the matrix metalloproteinase 9 (MMP9) [54]. CXCR2 signalling was
previously shown to lead to NAPDH-oxidase (NOX)-dependent
generation of ROS and cell death [55]. In contrast, recently the reac-
tive oxygen species generated via the phagocyte NADPH oxidase 2
(NOX2) complex were shown to contribute to the resolution of
inﬂammation [56]. We observed decreased intracellular superoxide
productiondespite increasedCXCR1 expression in active TBpatients.
DecreasedCXCR1 induced superoxide production can be achievedby
the mechanisms of desentization [57,58]. Leukocyte deactivation is
also found in septic patients and function as a negative predictor of
survival [59,60]. Furthermore, since phagocytosis is known to down-
regulate the expression of CXCR1 and CXCR2 [61], our data suggests
that a non-functional CXCR1 could explain the impaired phagocy-
tosis observed in active TB patients. Blocking of CXCR1 in healthy
volunteers resulted in decreased intracellular superoxide produc-
tion, supporting our hypothesis on impaired CXCR1 function. A
cleaved CXCR1 was recently observed to disable bacterial killing in
patients with chronic pulmonary diseases [32]. Our next stepwill be
to investigate the cause behind the impaired receptor function.
The global burden of TB remains high, but the determinants of
susceptibility to severe infection and latent disease remain poorly
understood. Tissue damage during TB arises primarily from the
immune response and not as a direct consequence of the bacterial
infection. In terms of rapid diagnosis, sputum microscopy will only
identify approximately 50% of patients with active pulmonary TB,
while IGRA cannot distinguish active TB from symptomatic patients
with latent infection. We identiﬁed distinct chemokine receptor
expression in pulmonary TB patients and LTBI subjects, and an
impact of these receptors on immune defence. This ﬁnding could
open up a new area of future therapies.
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